A multi-center diabetes eye screening study in community settings: Study design and methodology

Ophthalmic Epidemiology

Volumn 23, Issue 2, 2016, Pages 109-115

  Murchison, Ann P ^a   Friedman, David S ^b   Gower, Emily W ^b,c   Haller, Julia A ^a   Lam, Byron L ^d   Lee, David J ^d   Mcgwin, Gerald ^e,f   Owsley, Cynthia ^e   Saaddine, Jinan ^g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Diabetes; eye screening; methodology; study design; tele ophthalmology

Indexed keywords

ANCESTRY GROUP; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; ETHNIC GROUP; EYE CARE; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; VISUAL ACUITY; ADULT; AGED; CLINICAL TRIAL; COMMUNITY CARE; DEVICES; FEASIBILITY STUDY; METHODOLOGY; MIDDLE AGED; MINORITY GROUP; MULTICENTER STUDY; PATIENT SELECTION; PHOTOGRAPHY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; VISION TEST;

ADULT; AGED; COMMUNITY HEALTH SERVICES; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; PATIENT SELECTION; PHOTOGRAPHY; PROSPECTIVE STUDIES; RESEARCH DESIGN; SURVEYS AND QUESTIONNAIRES; UNITED STATES; VISION SCREENING; VISUAL ACUITY;

EID: 84961213684     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2015.1099682     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States., 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011, 3
2. Congdon N, OColmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477-485
3. Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 2004; 122: 487-494
4. Lee PP, Feldman ZW, Ostermann J, et al. Longitudinal prevalence of major eye diseases. Arch Ophthalmol 2003; 121: 1303-1310
5. Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA 2006; 295: 2158-2163
6. Kempen JH, OColmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004; 122: 552-563
7. Saaddine JB, Honeycutt AA, Narayan KM, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol 2008; 126: 1740-1747
8. Klein R, Klein BE, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988; 260: 2864-2871
9. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156-163
10. Rowe S, MacLean CH, Shekelle PG. Preventing visual loss from chronic eye disease in primary care: scientific review. JAMA 2004; 291: 1487-1495
11. Group TDRSR. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981; 88: 583-600
12. Group ETDRSR. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796-1806
13. Committee AAoOPPP. Preferred practice pattern guidelines. Comprehensive adult medical eye evaluation. San Francisco, CA: American Academy of Ophthalmology, 2010
14. Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes Care 2003; 26 (. Suppl. 1): S99-S102
15. Cavallerano J, Cooppan R. Optometric clinical practice guideline: care of the patient with diabetes mellitus. American Optometric Association 2002; 243: 63141-7881
16. Zhang X, Saaddine JB, Lee PP, et al. Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol 2007; 125: 411-418
17. Schoenfeld ER, Greene JM, Wu SY, et al. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 2001; 108: 563-571
18. Maclennan PA, McGwin G, Jr., Heckemeyer C, et al. Eye care use among a high-risk diabetic population seen in a public hospitals clinics. JAMA Ophthalmol 2013; 132: 162-167
19. Bragge P, Gruen RL, Chau M, et al. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol 2011; 129: 435-444
20. Silva PS, Cavallerano JD, Aiello LM, et al. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol 2011; 129: 236-242
21. Williams GA, Scott IU, Haller JA, et al. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004; 111: 1055-1062
22. Harding S, Greenwood R, Aldington S, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003; 20: 965-971